Louis W. Sullivan
Director, Bristol-Myers Squibb.
Companies
- Emergent BioSolutionsBoard member Nov 14, 2006 to now1
- UNITED THERAPEUTICS CorpBoard member Jul 10, 2006 to now2
- Henry ScheinBoard member Mar 3, 2006 to Apr 4, 20163
- ANI PHARMACEUTICALS INCBoard member Mar 20, 2006 to Mar 30, 20124
- The Cigna GroupBoard member Jan 4, 2006 to Jun 1, 20065
- 3MBoard member Aug 13, 2003 to May 11, 20066
- Bristol-Myers SquibbBoard member Jul 2, 2003 to Apr 4, 20067
- EquifaxBoard member Jul 2, 2003 to Jan 3, 20058
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
3M MMM21,907 shares9$3.6M at $164.36May 11, 2006- UNITED THERAPEUTICS Corp UTHR4,440 shares10$2.4M at $544.42Jul 23, 2026
Equifax EFX6,033 shares11$961.1K at $159.30May 5, 2004
Emergent BioSolutions EBS139,098 shares12$899.3K at $6.46Apr 30, 2025
Bristol-Myers Squibb BMY8,400 shares13$501.3K at $59.67Apr 29, 2005
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 9, 2026Exercised options 650 shares of UNITED THERAPEUTICS Corp14
- Dec 22, 2025Sold 4,863 shares at $512.34 of UNITED THERAPEUTICS Corp15
- Dec 22, 2025Sold 1,087 shares at $511.22 of UNITED THERAPEUTICS Corp15
- Dec 22, 2025Exercised options 2,720 shares at $229.81 of UNITED THERAPEUTICS Corp15
- Dec 22, 2025Exercised options 3,230 shares at $183.98 of UNITED THERAPEUTICS Corp15
- Jul 25, 2025Exercised options 590 shares of UNITED THERAPEUTICS Corp16
- Apr 30, 2025Granted 34,403 shares of Emergent BioSolutions12
- Dec 19, 2024Gift 1,851 shares of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 100 shares at $382.25 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 800 shares at $381.37 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 944 shares at $379.67 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 400 shares at $377.46 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 2,700 shares at $375.03 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 1,962 shares at $374.17 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 1,525 shares at $373.06 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 100 shares at $370.78 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 1,926 shares at $370.02 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 752 shares at $368.67 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 100 shares at $382.63 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 620 shares at $381.41 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 700 shares at $380.12 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 200 shares at $379.30 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 500 shares at $374.46 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 2,200 shares at $375.00 of UNITED THERAPEUTICS Corp17
- Dec 18, 2024Sold 2,451 shares at $374.14 of UNITED THERAPEUTICS Corp17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAREmergent BioSolutions, Board member
- 2
- 3SEC EDGARHenry Schein, Board member
- 4
- 5SEC EDGARThe Cigna Group, Board member
- 6SEC EDGAR3M, Board member
- 7SEC EDGARBristol-Myers Squibb, Board member
- 8SEC EDGAREquifax, Board member
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARForm 4 filed Jul 13, 2026
- 15SEC EDGARForm 4 filed Dec 23, 2025
- 16SEC EDGARForm 4 filed Jul 28, 2025
- 17SEC EDGARForm 4 filed Dec 19, 2024